Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 21,040 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Fertility Risk
Interventions: Blood draw through TAP II, Blood draw through ADx cardT, Blood draw through standard venipuncture; Diagnostic Test
Lead sponsor: Turtle Health, Inc.; Industry
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Psoriasis
Interventions: Cyclosporine; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Cataract, Aphakia
Interventions: Clareon IOL, Clareon Toric IOL, Eyhance IOL, Eyhance Toric IOL, Phacoemulsification surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 203 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 8
States / cities: Poughkeepsie, New York • Brecksville, Ohio • Mt. Pleasant, South Carolina + 4 more

Conditions: Cognition Improvement, Cognition Function
Interventions: Necternal Supplement, Placebo; Dietary Supplement
Lead sponsor: Necternal LLC; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Gulf War Illness
Interventions: Nicotinamide Riboside, Placebo; Dietary Supplement
Lead sponsor: Roskamp Institute Inc.; Other
Eligibility: 47 Years to 70 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Fort Lauderdale, Florida • Sarasota, Florida

Conditions: Voiding Disorders, Overactive Bladder, Urinary Incontinence
Interventions: Lidocaine gel 2%, Standard lubricant gel; Drug · Other
Lead sponsor: Atlantic Health System; Other
Eligibility: 40 Years to 80 Years · Female only
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Nicotine Dependence
Interventions: Amphetamine; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Screening Compliance, Lung Cancer (Diagnosis), Lung Cancer Diagnosis, Lung Cancer
Interventions: Facilitated referral and text messaging, Basic Referral (enhanced control arm); Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 50 Years to 80 Years
Enrollment: 349 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Ptsd
Interventions: Interview; Other
Lead sponsor: Life University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Beta-Thalassemia
Interventions: VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID, Placebo; Drug
Lead sponsor: Vifor (International) Inc.; Industry
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Whittier, California

Conditions: Stroke, Hemiparesis
Interventions: Split Belt treadmill; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 2 Years to 80 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Diabetes Mellitus, Type 2
Interventions: linagliptin; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 19
States / cities: Chula Vista, California • Spring Valley, California • Walnut Creek, California + 16 more

Conditions: Atrial Fibrillation, Percutaneous Coronary Intervention
Interventions: rivaroxaban 2.5 mg, rivaroxaban 15 mg, rivaroxaban 10 mg, aspirin (ASA), vitamin K antagonist (VKA), clopidogrel, prasugrel, ticagrelor; Drug
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 2,124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 86
States / cities: Huntsville, Alabama • Los Alamitos, California • Mission Viejo, California + 83 more

Conditions: Diffuse Intrinsic Pontine Glioma
Interventions: Gemcitabine; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 3 Years to 17 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Stroke, Acute, Cerebral Infarction
Interventions: Endovascular Thrombectomy, Trevo Retriever, Solitaire™ FR Revascularization Device, Penumbra thrombectomy system, Covidien MindFrame Capture Revascularization Device; Procedure · Device
Lead sponsor: Gregory W Albers; Other
Eligibility: 18 Years to 90 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 40
States / cities: Birmingham, Alabama • Fresno, California • La Jolla, California + 26 more

Conditions: Asthma
Interventions: Osteopathic Manipulative Treatment - in clinic, Osteopathic Manipulative Treatment - at home, Education to physicians; Procedure · Other
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 5 Years to 55 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Parkinson Disease
Interventions: Protein Redistribution Diet, Protein Consistent Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 45 Years to 99 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Cancer
Interventions: LY2603618, Desipramine, Pemetrexed, Gemcitabine; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Sedentary Lifestyle
Interventions: Cardiorespiratory fitness training, Functional fitness training; Behavioral
Lead sponsor: Michelle W. Voss; Other
Eligibility: 55 Years to 80 Years
Enrollment: 122 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Colorectal Cancer
Interventions: bevacizumab, cetuximab, FOLFOX or, FOLFIRI; Biological · Drug
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 2,334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2018
U.S. locations: 662
States / cities: Mobile, Alabama • Anchorage, Alaska • Fort Smith, Arkansas + 468 more

Conditions: Idiopathic Hypersomnia
Interventions: Low Sodium Oxybate, 24-hour polysomnography, Nextsense EEG earbuds, Axivity device; Drug · Diagnostic Test · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: Phoenix, Arizona • Redwood City, California • Jacksonville, Florida + 1 more

Conditions: Overactive Bladder
Interventions: Mirabegron 50 MG, Posterior Tibial Nerve Stimulation (PTNS); Drug · Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Female only
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Diabetes Mellitus, Type 2
Interventions: CHW Intervention; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 25 Years to 85 Years
Enrollment: 441 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Hip Pain
Interventions: Unrestrained Femoral Internal Rotation (UFIR) manipulation, Sham manipulation; Other
Lead sponsor: Andrews University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Columbia, Maryland

Search by objective public record fields.

Anti-Mullerian Hormone - At My Home

The Effectiveness of Lower Cyclosporine Doses for Psoriasis

Clareon Toric vs Eyhance Toric

A Clinical Study to Evaluate the Effects of a Supplement on Cognitive Function

Nicotinamide Riboside Clinical Trial for GWI

Lidocaine for Pain After Urodynamic Testing

Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

PTSD Interview Regarding Future Study Design and Equipment.

Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia

Locomotor Training for Neurological Disease

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma

Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

Effect of OMT on Asthma Symptoms in Southwest Virginia

Optimizing Protein Patterns for Skeletal Muscle Preservation and Sleep in the Medical Management of Parkinson Disease

A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine

Exercise Effects on Brain Health and Learning From Minutes to Months

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)

DREAM Project Community Health Worker Intervention

Hip Manipulation for Improved Strength in Patients With Hip Pain